Effects of Localized Hydrophilic Mannitol and Hydrophobic Nelfinavir Administration Targeted to Olfactory Epithelium on Brain Distribution

No abstract is available for this paper.

• Publication year

  2011

• Venue

  AAPS PharmSciTech

• Publication date

  2011-04-26

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1208/s12249-011-9614-1PMID 21519984PMCID PMC3134660
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nelfinavir

  2012influential reference
• NeuroAIDS

  2012cited by this paper
• Examination of the ability of the nasal administration route to confer a brain exposure advantage for three chemical inhibitors of P-glycoprotein.

  2010cited by this paper
• Intranasal delivery to the central nervous system: mechanisms and experimental considerations.

  2010influential reference
• Intranasal Deferoxamine Provides Increased Brain Exposure and Significant Protection in Rat Ischemic Stroke

  2009cited by this paper
• Evaluation of Direct Transport Pathways of Glycine Receptor Antagonists and an Angiotensin Antagonist from the Nasal Cavity to the Central Nervous System in the Rat Model

  2008cited by this paper
• Inhibition of P-glycoprotein Activity at the Primate Blood-Brain Barrier Increases the Distribution of Nelfinavir into the Brain but Not into the Cerebrospinal Fluid

  2007cited by this paper
• Can Nasal Drug Delivery Bypass the Blood-Brain Barrier?

  2007cited by this paper
• Nasal administration of an angiotensin antagonist in the rat model: effect of bioadhesive formulations on the distribution of drugs to the systemic and central nervous systems.

  2007cited by this paper
• Strategies for Intranasal Delivery of Therapeutics for the Prevention and Treatment of NeuroAIDS

  2007influential reference
• The Influence of Spray Properties on Intranasal Deposition

  2007cited by this paper
• Transfer of morphine along the olfactory pathway to the central nervous system after nasal administration to rodents.

  2005cited by this paper
• Localization and Differential Activity of P-glycoprotein in the Bovine Olfactory and Nasal Respiratory Mucosae

  2005cited by this paper
• Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.

  2004cited by this paper
• Drug delivery to the nasal cavity: in vitro and in vivo assessment.

  2004cited by this paper
• Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis.

  2004cited by this paper
• Is nose‐to‐brain transport of drugs in man a reality?

  2004cited by this paper
• Functional Evidence for P-glycoprotein at the Nose-Brain Barrier

  2004cited by this paper
• Hydroxocobalamin Uptake into the Cerebrospinal Fluid after Nasal and Intravenous Delivery in Rats and Humans

  2003cited by this paper
• P-Glycoprotein Attenuates Brain Uptake of Substrates After Nasal Instillation

  2003cited by this paper
• Visualization of In Vivo Olfactory Uptake and Transfer Using Fluorescein Dextran

  2002cited by this paper
• Direct nose-brain transport of benzoylecgonine following intranasal administration in rats.

  2001cited by this paper
• Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage.

  2001cited by this paper
• Delivery of Neurotrophic Factors to the Central Nervous System

  2001cited by this paper
• Levels of dopamine in blood and brain following nasal administration to rats.

  2001cited by this paper
• Transfer of Dopamine in the Olfactory Pathway Following Nasal Administration in Mice

  2000cited by this paper
• Transport of drugs from the nasal cavity to the central nervous system.

  2000cited by this paper
• Direct transport of cocaine from the nasal cavity to the brain following intranasal cocaine administration in rats.

  1999cited by this paper
• Applied anatomy and physiology of the nose and paranasal sinuses

  1999cited by this paper
• Rapid and simultaneous quantification of rhamnose, mannitol, and lactulose in urine by HPLC for estimating intestinal permeability in pediatric practice.

  1996cited by this paper
• Quantitative analysis of the olfactory pathway for drug delivery to the brain.

  1995cited by this paper
• Morphology of the human olfactory epithelium

  1990cited by this paper
• Mannitol pharmacokinetics and serum osmolality in dogs and humans.

  1986cited by this paper
• Comparative morphometry of the nasal cavity in rats and mice.

  1982cited by this paper
• Histopathologic examination of the rat nasal cavity.

  1981cited by this paper
• Subarachnoid space of the CNS, nasal mucosa, and lymphatic system.

  1979cited by this paper
• Brain distribution spaces of mannitol-3H, inulin-14C, and dextran-14C in the rat.

  1971cited by this paper
• Mechanism of increased renal sodium excretion following mannitol infusion in man.

  1955cited by this paper

• More Than Three Decades After Discovery of the Neuroprotective Effect of PACAP, What Is Still Preventing Its Clinical Use?

  2025cites this paper
• Differential targeting of olfactory epithelium and respiratory epithelium in nose-to-brain drug delivery

  2025cites this paper
• Characterization of a custom 3D-printed microfluidic aerosolizer for enhanced nose-to-brain delivery of nanoemulsion.

  2025cites this paper
• Refinement of intranasal delivery in rats: A cadaveric study

  2024influential citation
• Nasal delivery of encapsulated recombinant ACE2 as a prophylactic drug for SARS-CoV-2.

  2024cites this paper
• To Explore Nasal-Brain Lymphatic System for Brain-Targeted Drug Delivery and to Treat Neurodegenerative Diseases.

  2024cites this paper
• The Potential of the Nose-to-Brain Delivery of PACAP for the Treatment of Neuronal Disease

  2023cites this paper
• Engineered dry powders for the nose-to-brain delivery of transforming growth factor-beta.

  2023cites this paper
• Fresh isolate adult telomerase positive stem cells: An addition to Embryonic Stem Cells (ESCs), Induced Pluripotent Stem Cells (iPSCs), and/or Mesenchymal Stem Cells (MSCs) for regenerative medicine

  2023cites this paper
• Impact of amino acids on the properties of nasal dry powders

  2023cites this paper
• INP104: a drug evaluation of a nonoral product for the acute treatment of migraine.

  2023cites this paper
• Engineered nasal dry powder for the encapsulation of bioactive compounds.

  2022cites this paper
• Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date

  2022cites this paper
• The Pharmacokinetics of Drug Delivery to the Upper Nasal Space: A Review of INP105 Development

  2022cites this paper
• Blunt Force Trauma-Induced Total Bilateral Visual Impairment of 13 Years Duration Treated with Autologous Telomerase-Positive Stem Cells

  2021cites this paper
• A technology overview on advanced drug administration devices for effective nose-to-brain delivery

  2021cites this paper
• Nose-to-brain delivery of antiretroviral drugs against NeuroAIDS

  2021cites this paper
• Numerical analysis of enhanced nano-drug delivery to the olfactory bulb

  2021cites this paper
• Treating Parkinson Disease with Autologous Telomerase-Positive Stem Cells, Update 2021

  2021cites this paper
• Recent strategies and advances in the fabrication of nano lipid carriers and their application towards brain targeting.

  2020cites this paper
• Factors influencing drug deposition in the nasal cavity upon delivery via nasal sprays

  2020cites this paper
• Characterization of Endogenous Telomerase-Positive Stem Cells for Regenerative Medicine, A Review

  2020cites this paper
• Non-Invasive Strategies for Nose-to-Brain Drug Delivery

  2020cites this paper
• Age-Related Macular Degeneration Treated with Autologous TelomerasePositive Totipotent Stem Cells

  2020cites this paper
• Electromagnetic Steering of Nanomedicine to the Olfactory Mucosa for Nose-to-Brain Drug Delivery

  2020cites this paper
• Factors influencing drug deposition in the nasal cavity upon delivery via nasal sprays

  2020cites this paper
• Intranasal delivery of low-dose insulin ameliorates motor dysfunction and dopaminergic cell death in a 6-OHDA rat model of Parkinson's Disease.

  2020cites this paper
• Liposomal Formulations for Nose-to-Brain Delivery: Recent Advances and Future Perspectives

  2019cites this paper
• Approaches for CNS delivery of drugs – nose to brain targeting of antiretroviral agents as a potential attempt for complete elimination of major reservoir site of HIV to aid AIDS treatment

  2019cites this paper
• Innovative sprayable in situ gelling fluticasone suspension: Development and optimization of nasal deposition

  2019cites this paper
• Perivascular and Perineural Pathways Involved in Brain Delivery and Distribution of Drugs after Intranasal Administration

  2019cites this paper
• Nose-to-Brain Delivery of Antiviral Drugs: A Way to Overcome Their Active Efflux?

  2018cites this paper
• Development of Binary Composite Solid Microparticles for Improved Intranasal Absorption of Low Permeation Drug Molecules

  2017cites this paper
• Numerical Simulation and Experimental Testing to Improve Olfactory Drug Delivery with Electric Field Guidance of Charged Particles

  2017cites this paper
• Intravenous Delivery of a D1-D2 Interfering Peptide with Antidepressant-like Effects

  2017cites this paper
• Progress in brain targeting drug delivery system by nasal route

  2017cites this paper
• Efavirenz loaded nanostructured lipid carrier engineered for brain targeting through intranasal route: In-vivo pharmacokinetic and toxicity study.

  2017cites this paper
• Optimization of magnetophoretic-guided drug delivery to the olfactory region in a human nose model

  2016cites this paper
• Modeling and Simulations of Olfactory Drug Delivery with Passive and Active Controls of Nasally Inhaled Pharmaceutical Aerosols.

  2016cites this paper
• Relative vascular permeability and vascularity across different regions of the rat nasal mucosa: implications for nasal physiology and drug delivery

  2016cites this paper
• Visualization and Quantification of Nasal and Olfactory Deposition in a Sectional Adult Nasal Airway Cast

  2016cites this paper
• Design and Testing of Electric-Guided Delivery of Charged Particles to the Olfactory Region: Experimental and Numerical Studies.

  2016cites this paper
• NOVEL APPROACH FOR NOSE-TO-BRAIN DRUG DELIVERY BYPASSING BLOOD BRAIN BARRIER BY PRESSURIZED OLFACTORY DELIVERY DEVICE

  2015influential citation
• Influence of Dosage Form, Formulation, and Delivery Device on Olfactory Deposition and Clearance: Enhancement of Nose-to-CNS Uptake

  2015cites this paper
• Design and Synthesis of Polymeric Nanoparticles for Drug and Protein Delivery

  2015cites this paper
• The Olfactory System as a Route of Delivery for Agents to the Brain and Circulation

  2015cites this paper
• Optimization of magnetophoretic-guided drug delivery to the olfactory region in a human nose model

  2015cites this paper
• Aerosol-stable peptide-coated liposome nanoparticles: a proof-of-concept study with opioid fentanyl in enhancing analgesic effects and reducing plasma drug exposure.

  2014cites this paper
• Intranasally-administered deferoxamine mitigates toxicity of 6-OHDA in a rat model of Parkinson׳s disease.

  2014cites this paper
• Intranasal Delivery of a Peptide with Antidepressant-Like Effect

  2014cites this paper
• Intranasal delivery of FSD‐C10, a novel Rho kinase inhibitor, exhibits therapeutic potential in experimental autoimmune encephalomyelitis

  2014cites this paper
• Back to the future: inhaled drug products.

  2013cites this paper
• Transferrin receptor antibody-modified α-cobrotoxin-loaded nanoparticles enable drug delivery across the blood–brain barrier by intranasal administration

  2013cites this paper
• CLINICAL TRIALS AND TRANSLATIONAL MEDICINE COMMENTARIES Back to the Future: Inhaled Drug Products

  2013cites this paper
• Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats

  2013cites this paper
• Title Delivery of high solubility polyols by vibrating mesh nebuliser toenhance mucociliary clearance

  2012cites this paper
• Delivery of High Solubility Polyols by Vibrating Mesh Nebulizer to Enhance Mucociliary Clearance

  2012cites this paper
• Nasal-to-CNS drug delivery: where are we now and where are we heading? An industrial perspective.

  2012cites this paper